Ashcombe advises on Investment in Kinapse

Ashcombe Advisers advised on the recent investment by Synova Capital in Kinapse, the leading provider of outsourced services to the global life sciences industry with a particular focus on the areas of regulatory and compliance services.

Kinapse counts 7 of the top 10 global life sciences companies as customers and regulatory organisations such as the European Medicines Agency. Kinapse operates a unique blended resourcing model enabling the Business to offer customers cost effective offshore solutions allied to input from industry-leading professionals based in the UK. The Group has offices in the UK, India and the United States.